Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
PBLS compared with LLY: revenue, margins and what each company keeps, and the suppliers and customers both name
PBLS
Parabilis Medicines, Inc.
Change
Mkt cap
Revenue
Revenue
LLY
ELI Lilly & Co
Change
Mkt cap
Revenue
Revenue
vs
Compare
PBLS
Parabilis Medicines, Inc.
vs
LLY
ELI Lilly & Co
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Price
Desk
News
Calendar
Saved
Search
PBLS
Parabilis Medicines, Inc.
Change
27.29
▼
−6.70%
· post 30.39
· delayed
Mkt cap
$845.6M
Revenue
$148,000
Q2 FY26
Revenue
—
LLY
ELI Lilly & Co
Change
1,417.89
▲
+0.60%
· post 1,421.50
· delayed
After hours
Nov 4 '26
delayed
Mkt cap
$1.3T
Revenue
$24.4B
Q3 FY26
Revenue
$65.2B
FY25
vs
Compare
After hours
Nov 4 '26
delayed
PBLS
Parabilis Medicines, Inc.
vs
LLY
ELI Lilly & Co
27.29
▼
−6.70%
post 30.39
delayed
Price
1,417.89
▲
+0.60%
post 1,421.50
delayed
$845.6M
Mkt cap
$1.3T
Q2 FY26
$148,000
Revenue
$24.4B
Q3 FY26
—
Revenue
$65.2B
FY25
Change
Change
PBLS
27.29
▼
−6.70%
vs
LLY
1,417.89
▲
+0.60%
After hours
Nov 4 '26
delayed
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
PBLS, solid
LLY, dashed